Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Clinical Others (COT)"'
Autor:
Takamitsu Fujiamaki, Kaoru Tamura, Tatsuya Abe, Mitsutoshi Nakada, Akiko Higuchi, Yuko Watanabe, Motoo Nagane
Publikováno v:
Neuro-oncology Advances
Gender Equality and Diversity Committee (“Women and Diversity in Neuro-oncology - WING”) of the Japan Society for Neuro-oncology (JSNO) was established in November 2020 with the aim of supporting and providing better opportunities for diverse mem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ffe1d4872b1032f6a06b57ca136a5f
http://europepmc.org/articles/PMC8648142
http://europepmc.org/articles/PMC8648142
Publikováno v:
Neuro-Oncology Advances
Neuro-oncology Advances
Neuro-oncology Advances
Background: EF-14 trial showed the efficacy of tumor treating fields (TTF), and TTF was approved as a standard therapy for glioblastoma. In TTF opening, Device Support Specialist (DSS) should explain how to use it for the patient and family. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92e085c39cad2210532b3d904324cd3
Autor:
Takahiro Ogawa, Norie Sawada, Motoki Iwasaki, Budhatoki Sanjeev, Taiki Yamaji, Taichi Shimazu, Yoshitaka Narita
Publikováno v:
Neuro-oncology Advances
Purpose: Because the prognosis of the malignant brain tumor including glioblastoma is extremely worse than other cancer, it is important to clarify the preventive factors of the brain tumor in the prospective cohort study. In the Japanese epidemiolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a39fe87308489a653409786a2351d6
http://europepmc.org/articles/PMC8648169
http://europepmc.org/articles/PMC8648169
Autor:
Junya Fukai, Takahiro Sasaki, Toshikazu Yamoto, Yasuo Nakai, Masamichi Ishii, Mari Kitayama, Hiroki Nishibayashi, Kanji Mori, Yonehiro Kanemura, Naoyuki Nakao
Publikováno v:
Neuro-oncology Advances
Introduction: In glioma patients, epilepsy not infrequently occurred and anti-epileptic drugs (AEDs) are commonly used. In this study, we revealed the real-world data on clinical practice of glioma-related epilepsy in Wakayama Medical University Hosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af3cc26b3b1a52a5107add6142393a7
http://europepmc.org/articles/PMC8648227
http://europepmc.org/articles/PMC8648227
Publikováno v:
Neuro-oncology Advances
Backgrounds: The demographic characteristics of Kumamoto Prefecture are that there is little population movement and the total population remains constant at about 1.8 million, but in recent years the birthrate is declining and the population is agin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcec147792fbd7a3f0fd48c339baba9c
https://doi.org/10.1093/noajnl/vdab159.119
https://doi.org/10.1093/noajnl/vdab159.119
Autor:
Negoto, Tetsuya, Komaki, Satoru, Moritsubo, Mayuko, Furuta, Takuya, Nakamura, Hideo, Morioka, Motohiro
Publikováno v:
Neuro-oncology Advances
Introduction: Pathological features of glioblastoma include intravascular thrombosis, suggesting that the thrombus formation in tumor microenvironment contributes to progression of gliomas. Meanwhile, glioblastoma has been known to be high risk malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb79dec7911d6fb08917e3db62ac9719
https://doi.org/10.1093/noajnl/vdab159.114
https://doi.org/10.1093/noajnl/vdab159.114
Autor:
Norihiko Saito, Nozomi Hirai, Naoki Kushida, Sho Sato, Yu Hiramoto, Satoshi Fujita, Haruo Nakayama, Morito Hayashi, Keisuke Ito, Satoshi Iwabuchi
Publikováno v:
Neuro-oncology Advances
Glioblastoma is the most common and most aggressive primary brain tumor. Even with optimal treatment, tumors repeatedly recur and grow, eventually invading the entire brain. Few studies have evaluated the pathogenesis and pathophysiology of terminal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9891956346979ce59f87173a3a537af4
http://europepmc.org/articles/PMC8648246
http://europepmc.org/articles/PMC8648246
Autor:
Kazufumi Ohmura, Etsuko Ohwashi, Yuka Ikegame, Hiroaki Takei, Kazuhiro Miwa, Hirohito Yano, Kazutoshi Yokoyama, Morio Kumagai, Jun Shinoda, Takashi Daimon, Noriyuki Nakayama, Toru Iwama
Publikováno v:
Neuro-oncology Advances
Aim: The amount of tumor excised in an area enhanced by contrast medium on magnetic resonance imaging strongly affects the survival time of patients with glioblastoma. We investigated the effect of the amount of tumor removal in the 11C methionine (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7deb3a933e9b59ef26714d9af471ebd
http://europepmc.org/articles/PMC8648143
http://europepmc.org/articles/PMC8648143
Autor:
Onishi, Shumpei, Yamasaki, Fumiyuki, Takayasu, Takeshi, Takano, Motoki, Yonezawa, Ushio, Taguchi, Akira, Kanda, Miyuki, Sugiyama, Kazuhiko, Tahara, Hidetoshi
Publikováno v:
Neuro-oncology Advances
Background Non-invasive biomarkers are required in clinical practice of glioblastoma (GBM). We have previously reported the liquid biopsy for differentiating glioblastoma, central nervous system primary lymphoma and healthy control. In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f8dfdaaf50a6b68d9d4db2bea5c570a
https://doi.org/10.1093/noajnl/vdab159.115
https://doi.org/10.1093/noajnl/vdab159.115
Publikováno v:
Neuro-oncology Advances
Brain tumors are a major shock at diagnosis for patients and their families, and the journey is hectic, impacted in various and complex ways, including acute and chronic episodes. The Japan Brain Tumor Alliance is a non-profit organisation, establish
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7308aabc9b19d1d9cea0e2f213dfa25a
https://doi.org/10.1093/noajnl/vdab159.121
https://doi.org/10.1093/noajnl/vdab159.121